HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new method of grading malignancy of prostate carcinoma using quantitative microscopic nuclear features.

Abstract
A morphometrical assessment of nuclear features and a DNA study were performed on prostate tissue specimens from 33 patients with prostate carcinoma using an image analysing computer. Six nuclear geometric variables were measured and their mean, standard deviation (SD) and standard error (SE) were calculated for each case. The data on nuclear DNA content obtained by static cytometry were processed using an algorithm which provided a DNA grade of malignancy (DNA MG). Using the stepwise multiple regression, we found a significant correlation (p less than 0.01) between the DNA MG, chosen as the dependent variable in the statistical model, and the following nuclear features in decreasing order of importance: area SD, convex perimeter SE, and the mean of maximum diameter. From the correlation coefficients of the variables an equation was built up which provided a geometric nuclear grade of malignancy (GNMG) on a morphometrical basis more closely related to the clinical stage of the tumour (r = 0.75) than the visually assessed histological grade (r = 0.68) based on the Gleason score. This new method of grading malignancy allows an objective and quantitative evaluation to be made of the biological behaviour of the tumour, as measured by the patient's clinical stage.
AuthorsF Robutti, F P Pilato, P G Betta
JournalPathology, research and practice (Pathol Res Pract) Vol. 185 Issue 5 Pg. 701-3 (Nov 1989) ISSN: 0344-0338 [Print] Germany
PMID2626378 (Publication Type: Journal Article)
Chemical References
  • DNA, Neoplasm
Topics
  • Cell Nucleus (pathology)
  • DNA, Neoplasm (analysis)
  • Humans
  • Image Processing, Computer-Assisted (methods)
  • Male
  • Prostatic Neoplasms (pathology, ultrastructure)
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: